ENRIQUE MARÍA OCIO SAN MIGUEL-rekin lankidetzan egindako argitalpenak (8)

2014

  1. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: Implications in myeloma progression and myeloma bone disease

    Oncotarget, Vol. 5, Núm. 18, pp. 8284-8305

2012

  1. Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects

    PLoS ONE, Vol. 7, Núm. 4

2008

  1. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

    Haematologica, Vol. 93, Núm. 9, pp. 1301-1309

2006

  1. Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation [1]

    Bone Marrow Transplantation

  2. Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)

    Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941

2005

  1. CD34+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation

    Leukemia and Lymphoma, Vol. 46, Núm. 2, pp. 177-183

  2. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena

    American Journal of Hematology, Vol. 78, Núm. 4, pp. 302-305

2003

  1. Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    Seminars in Oncology, Vol. 30, Núm. 2, pp. 187-195